Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2019-07-09 04:26 2019-07-03 EIDX N/A BridgeBio Pharma, Inc. 10% owner Other BUY $29.90 882,353 $26,382,796 24,575,501 +3.7%
2019-07-09 04:32 2019-07-03 EIDX N/A Satvat Ali J. Director, 10% owner Other BUY $29.90 882,353 $26,382,796 24,575,501 +3.7%
2019-07-08 23:45 2019-07-05 ABQQ AI Era Corp. Deng Chiyuan Director, Officer, 10% owner - Chief Executive Officer Patent Owners & Lessors BUY $2.00 600,000 $1,200,000 2,000,400 +42.8%
2019-07-09 04:29 2019-07-03 EIDX N/A AGUIAR ERIC Director, 10% owner Other BUY $29.90 882,353 $26,382,796 24,575,501 +3.7%
2019-07-05 23:13 2019-05-29 UCBB N/A Huang Qingxi Director, Officer, 10% owner - CEO, CFO, Secy., Treas. Other BUY $214,500.00 4,290,000 $920,205,000,000 12,422,000 +52.8%
2019-07-05 23:13 2019-05-29 UCBB N/A China Israel Biotechnology Co. Ltd 10% owner Other BUY $214,500.00 4,290,000 $920,205,000,000 10,922,000 +64.7%
2019-07-05 23:05 2019-07-02 CHAP N/A Strategic Value Partners, LLC 10% owner Other BUY $4.64 486,895 $2,258,073 2,983,793 +19.5%
2019-07-03 15:39 2019-07-02 N-A N/A STRS OHIO 10% owner Other BUY $15.00 333,333 $5,000,000 4,602,683 +7.8%
2019-07-03 22:12 2019-07-02 N/A N/A Golub Lawrence E Director, Officer - Chairman Other BUY $15.00 125,035 $1,875,525 277,733 +81.9%
2019-07-03 22:13 2019-07-02 N/A N/A Golub David Director, Officer - President and CEO Other BUY $15.00 125,035 $1,875,525 277,733 +81.9%
2019-07-03 23:30 2019-07-01 BBIO BridgeBio Pharma, Inc. KKR Genetic Disorder L.P. 10% owner Pharmaceutical Preparations BUY $17.00 2,647,100 $45,000,700 36,900,661 +7.7%
2019-07-02 23:37 2019-06-28 VRML Aspira Women's Health Inc. Schuler Henri George 10% owner In Vitro & In Vivo Diagnostic Substances BUY $0.80 4,750,000 $3,800,000 1,503,177 +100.0%
2019-07-02 21:29 2019-03-13 CNFR Presurance Holdings, Inc. Hakala Jeffrey Anthony Director Fire, Marine & Casualty Insurance BUY $4.23 545,397 $2,307,684 768,161 +244.8%
2019-07-03 00:16 2019-07-02 OCX Insight Molecular Diagnostics Inc. BROADWOOD PARTNERS, L.P. 10% owner In Vitro & In Vivo Diagnostic Substances BUY $2.00 1,000,000 $2,000,000 9,098,267 +12.3%
2019-07-03 00:10 2019-07-02 KRTX N/A HEALY JAMES Director Other BUY $16.00 700,000 $11,200,000 1,729,352 +68.0%
2019-07-03 00:13 2019-07-02 KRTX N/A NELSEN ROBERT Director, 10% owner Other BUY $16.00 200,000 $3,200,000 1,681,435 +13.5%
2019-07-03 00:09 2019-07-02 KRTX N/A ARCH Venture Partners IX, LLC 10% owner Other BUY $16.00 200,000 $3,200,000 100,000 +100.0%
2019-07-03 00:13 2019-07-01 ADPT Adaptive Biotechnologies Corporation VIKING GLOBAL PERFORMANCE LLC 10% owner Biological Products, (No Diagnostic Substances) BUY $20.00 250,000 $5,000,000 1,675,000 +17.5%
2019-07-02 23:13 2019-07-01 MORF N/A GLAXOSMITHKLINE PLC Director Other BUY $15.00 333,333 $4,999,995 2,633,772 +14.5%
2019-07-03 00:11 2019-07-01 ADPT Adaptive Biotechnologies Corporation VIKING GLOBAL INVESTORS LP 10% owner Biological Products, (No Diagnostic Substances) BUY $20.00 250,000 $5,000,000 1,675,000 +17.5%
2019-07-02 23:36 2019-06-28 VRML Aspira Women's Health Inc. SCHULER JACK W 10% owner In Vitro & In Vivo Diagnostic Substances BUY $0.80 5,000,000 $4,000,000 22,378,242 +28.8%
2019-07-02 00:24 2019-06-27 MOTS Motus GI Holdings Inc. FEINBERG LARRY N 10% owner Surgical & Medical Instruments & Apparatus BUY $3.00 1,031,666 $3,095,514 30,000 +100.0%
2019-07-02 02:23 2019-07-01 MORF N/A Goyal Vikas Director Other BUY $15.00 333,333 $4,999,995 2,633,772 +14.5%
2019-07-02 02:19 2019-07-01 MORF N/A Nashat Amir Director Other BUY $15.00 125,000 $1,875,000 151,879 +465.0%
2019-07-01 23:31 2019-06-28 MORF N/A Novo Holdings A/S 10% owner Other BUY $15.00 666,667 $10,000,005 2,645,446 +33.7%
2019-07-02 03:01 2019-07-01 MORF N/A Stampacchia Otello Director, 10% owner Other BUY $15.00 133,333 $1,999,995 2,969,582 +4.7%
2019-07-02 02:55 2019-07-01 MORF N/A Omega Fund V, L.P. 10% owner Other BUY $15.00 133,333 $1,999,995 2,969,582 +4.7%
2019-07-02 01:16 2019-06-27 CRVS Corvus Pharmaceuticals, Inc. Thompson Peter A. Director, 10% owner Pharmaceutical Preparations BUY $3.72 657,344 $2,444,071 6,624,928 +11.0%
2019-07-02 02:23 2019-06-27 DOVA N/A PERCEPTIVE ADVISORS LLC 10% owner Other BUY $13.35 427,209 $5,703,197 3,553,060 +13.7%
2019-07-02 02:22 2019-06-27 MOTS Motus GI Holdings Inc. PERCEPTIVE ADVISORS LLC 10% owner Surgical & Medical Instruments & Apparatus BUY $3.00 1,000,000 $3,000,000 4,210,542 +31.1%
2019-07-01 23:36 2019-06-28 ACFN Acorn Energy Inc. LOEB JAN H Director, Officer, 10% owner - President and CEO Services-Engineering Services BUY $0.24 5,409,062 $1,298,175 4,372,017 +100.0%
2019-07-01 17:02 2019-06-28 TRC TEJON RANCH CO DT Four Partners, LLC 10% owner Real Estate BUY $16.50 70,097 $1,156,601 1,034,550 +7.3%
2019-07-02 01:15 2019-06-27 CRVS Corvus Pharmaceuticals, Inc. ORBIMED ADVISORS LLC Director, 10% owner Pharmaceutical Preparations BUY $3.72 657,344 $2,444,071 6,624,928 +11.0%
2019-07-01 16:43 2019-06-28 CSU SONIDA SENIOR LIVING, INC. Levinson Sam 10% owner Services-Nursing & Personal Care Facilities BUY $5.03 900,000 $4,527,000 4,615,921 +24.2%
2019-07-01 18:50 2019-06-27 ARQL N/A Nussbaum Ran Director Other BUY $9.75 307,692 $2,999,997 36,923 +100.0%
2019-06-29 00:03 2019-06-28 CMBM Cambium Networks Corp Amen Robert S Director, 10% owner Radio & Tv Broadcasting & Communications Equipment BUY $12.00 1,500,000 $18,000,000 18,000 +100.0%
2019-06-29 00:13 2019-06-26 IMMU N/A Avoro Capital Advisors LLC Director, 10% owner, Other Other BUY $13.55 1,000,000 $13,548,000 21,000,000 +5.0%
2019-06-28 23:47 2019-06-26 ABBV AbbVie Inc. CHASE WILLIAM J Officer - EVP, Finance & Administration Pharmaceutical Preparations BUY $67.30 30,400 $2,045,920 169,552 +21.8%
2019-06-28 23:30 2019-06-26 ODT N/A Boxer Capital, LLC 10% owner Other BUY $26.00 384,615 $9,999,990 3,363,377 +12.9%
2019-06-29 00:54 2019-06-28 CMBM Cambium Networks Corp VECTOR CAPITAL, L.L.C. Director, 10% owner Radio & Tv Broadcasting & Communications Equipment BUY $12.00 1,500,000 $18,000,000 18,000 +100.0%
2019-06-29 00:06 2019-06-28 CMBM Cambium Networks Corp Slusky Alexander R Director, 10% owner Radio & Tv Broadcasting & Communications Equipment BUY $12.00 1,500,000 $18,000,000 18,000 +100.0%
2019-06-29 00:44 2019-06-26 MGM MGM Resorts International Meister Keith A. Director Hotels & Motels BUY $27.99 209,136 $5,853,424 20,563,696 +1.0%
2019-06-28 23:01 2019-06-26 ODT N/A TANG KEVIN C Director, Officer, 10% owner - Chief Executive Officer Other BUY $26.00 769,231 $20,000,006 14,075,269 +5.8%
2019-06-29 00:47 2019-06-26 RUN Sunrun Inc. TIGER GLOBAL MANAGEMENT LLC 10% owner Miscellaneous Electrical Machinery, Equipment & Supplies BUY $18.59 866,725 $16,110,684 12,792,766 +7.3%
2019-06-29 02:02 2019-06-27 BBIO BridgeBio Pharma, Inc. VIKING GLOBAL PERFORMANCE LLC 10% owner Pharmaceutical Preparations BUY $17.00 4,705,900 $80,000,300 26,620,991 +21.5%
2019-06-28 23:10 2019-06-28 BECN N/A CD&R Investment Associates IX, Ltd. 10% owner Other BUY $34.17 4,625,998 $158,081,454 10,550,161 +78.1%
2019-06-29 03:19 2019-06-28 MDCO N/A DENNER ALEXANDER J Director Other BUY $33.00 50,000 $1,650,000 4,202,000 +1.2%
2019-06-29 02:02 2019-06-27 BBIO BridgeBio Pharma, Inc. VIKING GLOBAL INVESTORS LP 10% owner Pharmaceutical Preparations BUY $17.00 4,705,900 $80,000,300 26,620,991 +21.5%
2019-06-28 01:29 2019-06-25 AMAG N/A ARMISTICE CAPITAL, LLC 10% owner Other BUY $8.87 498,016 $4,415,858 200,000 +100.0%
2019-06-28 00:36 2019-06-25 FSLY Fastly, Inc. Abdiel Capital Management, LLC 10% owner Services-Prepackaged Software BUY $17.25 153,248 $2,643,206 2,253,248 +7.3%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.